APO Research
Talk to an analyst

APO RESEARCH · REPORT

Integrase Inhibitors

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Integrase Inhibitors Industry Growth and Trends Forecast to 2032

29 December 202597 pages

Choose your research edition.

Industry ResearchIntegrase Inhibitors Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Integrase Inhibitors Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Integrase Inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Integrase Inhibitors Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Integrase Inhibitors Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Integrase Inhibitors market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Integrase Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Integrase Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Integrase Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Integrase Inhibitors include Merck, Mylan, GlaxoSmithKline, Micro Labs, Laurus Labs, Hetero Drugs, Gilead Sciences, Cipla and Aurobindo Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Integrase Inhibitors market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Integrase Inhibitors market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Integrase Inhibitors market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Integrase Inhibitors.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Integrase Inhibitors market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Integrase Inhibitors Market by Company

Merck

Mylan

GlaxoSmithKline

Micro Labs

Laurus Labs

Hetero Drugs

Gilead Sciences

Cipla

Aurobindo Pharma

Integrase Inhibitors Segment by Type

Elvitegravir

Bictegravir

Dolutegravir

Raltegravir

Integrase Inhibitors Segment by Application

Clinic

Hospital

Integrase Inhibitors Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Integrase Inhibitors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Integrase Inhibitors and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Integrase Inhibitors.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Integrase Inhibitors manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Integrase Inhibitors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Elvitegravir Table 2. Major Company of Bictegravir Table 3. Major Company of Dolutegravir Table 4. Major Company of Raltegravir Table 5. Global Integrase Inhibitors Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Integrase Inhibitors Sales by Type (2021-2026) & (K Units) Table 7. Global Integrase Inhibitors Sales Market Share in Volume by Type (2021-2026) Table 8. Global Integrase Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 9. Global Integrase Inhibitors Sales Market Share in Value by Type (2021-2026) Table 10. Global Integrase Inhibitors Price by Type (2021-2026) & (US$/Unit) Table 11. Global Integrase Inhibitors Sales by Type (2027-2032) & (K Units) Table 12. Global Integrase Inhibitors Sales Market Share in Volume by Type (2027-2032) Table 13. Global Integrase Inhibitors Sales by Type (2027-2032) & (US$ Million) Table 14. Global Integrase Inhibitors Sales Market Share in Value by Type (2027-2032) Table 15. Global Integrase Inhibitors Price by Type (2027-2032) & (US$/Unit) Table 16. North America Integrase Inhibitors Sales by Type (2021-2026) & (K Units) Table 17. North America Integrase Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Integrase Inhibitors Sales by Type (2021-2026) & (K Units) Table 19. Europe Integrase Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Integrase Inhibitors Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Integrase Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Integrase Inhibitors Sales by Type (2021-2026) & (K Units) Table 23. Latin America Integrase Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Integrase Inhibitors Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Integrase Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 26. Integrase Inhibitors Industry Trends Table 27. Integrase Inhibitors Industry Drivers Table 28. Integrase Inhibitors Industry Opportunities and Challenges Table 29. Integrase Inhibitors Industry Restraints Table 30. Global Integrase Inhibitors Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Integrase Inhibitors Revenue Market Share by Company (2021-2026) Table 32. Global Integrase Inhibitors Sales by Company (2021-2026) & (K Units) Table 33. Global Integrase Inhibitors Sales Share by Company (2021-2026) Table 34. Global Integrase Inhibitors Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Integrase Inhibitors Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Integrase Inhibitors Major Company Production Sites and Headquarters Table 37. Global Integrase Inhibitors Company, Product Type & Application Table 38. Global Integrase Inhibitors Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Integrase Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Integrase Inhibitors Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Integrase Inhibitors Sales by Region (2021-2026) & (K Units) Table 43. Global Integrase Inhibitors Sales Market Share in Volume by Region (2021-2026) Table 44. Global Integrase Inhibitors Sales by Region (2021-2026) & (US$ Million) Table 45. Global Integrase Inhibitors Sales Market Share in Value by Region (2021-2026) Table 46. Global Integrase Inhibitors Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Integrase Inhibitors Sales by Region (2027-2032) & (K Units) Table 48. Global Integrase Inhibitors Sales Market Share in Volume by Region (2027-2032) Table 49. Global Integrase Inhibitors Sales by Region (2027-2032) & (US$ Million) Table 50. Global Integrase Inhibitors Sales Market Share in Value by Region (2027-2032) Table 51. Global Integrase Inhibitors Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Integrase Inhibitors Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Integrase Inhibitors Sales by Application (2021-2026) & (K Units) Table 54. Global Integrase Inhibitors Sales Market Share in Volume by Application (2021-2026) Table 55. Global Integrase Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 56. Global Integrase Inhibitors Sales Market Share in Value by Application (2021-2026) Table 57. Global Integrase Inhibitors Price by Application (2021-2026) & (US$/Unit) Table 58. Global Integrase Inhibitors Sales by Application (2027-2032) & (K Units) Table 59. Global Integrase Inhibitors Sales Market Share in Volume by Application (2027-2032) Table 60. Global Integrase Inhibitors Sales by Application (2027-2032) & (US$ Million) Table 61. Global Integrase Inhibitors Sales Market Share in Value by Application (2027-2032) Table 62. Global Integrase Inhibitors Price by Application (2027-2032) & (US$/Unit) Table 63. North America Integrase Inhibitors Sales by Application (2021-2026) & (K Units) Table 64. North America Integrase Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Integrase Inhibitors Sales by Application (2021-2026) & (K Units) Table 66. Europe Integrase Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Integrase Inhibitors Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Integrase Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Integrase Inhibitors Sales by Application (2021-2026) & (K Units) Table 70. Latin America Integrase Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Integrase Inhibitors Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Integrase Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 73. Merck Company Information Table 74. Merck Business Overview Table 75. Merck Integrase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Merck Integrase Inhibitors Product Portfolio Table 77. Merck Recent Development Table 78. Mylan Company Information Table 79. Mylan Business Overview Table 80. Mylan Integrase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Mylan Integrase Inhibitors Product Portfolio Table 82. Mylan Recent Development Table 83. GlaxoSmithKline Company Information Table 84. GlaxoSmithKline Business Overview Table 85. GlaxoSmithKline Integrase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. GlaxoSmithKline Integrase Inhibitors Product Portfolio Table 87. GlaxoSmithKline Recent Development Table 88. Micro Labs Company Information Table 89. Micro Labs Business Overview Table 90. Micro Labs Integrase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Micro Labs Integrase Inhibitors Product Portfolio Table 92. Micro Labs Recent Development Table 93. Laurus Labs Company Information Table 94. Laurus Labs Business Overview Table 95. Laurus Labs Integrase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Laurus Labs Integrase Inhibitors Product Portfolio Table 97. Laurus Labs Recent Development Table 98. Hetero Drugs Company Information Table 99. Hetero Drugs Business Overview Table 100. Hetero Drugs Integrase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Hetero Drugs Integrase Inhibitors Product Portfolio Table 102. Hetero Drugs Recent Development Table 103. Gilead Sciences Company Information Table 104. Gilead Sciences Business Overview Table 105. Gilead Sciences Integrase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Gilead Sciences Integrase Inhibitors Product Portfolio Table 107. Gilead Sciences Recent Development Table 108. Cipla Company Information Table 109. Cipla Business Overview Table 110. Cipla Integrase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Cipla Integrase Inhibitors Product Portfolio Table 112. Cipla Recent Development Table 113. Aurobindo Pharma Company Information Table 114. Aurobindo Pharma Business Overview Table 115. Aurobindo Pharma Integrase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Aurobindo Pharma Integrase Inhibitors Product Portfolio Table 117. Aurobindo Pharma Recent Development Table 118. North America Integrase Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 119. North America Integrase Inhibitors Sales by Country (2021-2026) & (K Units) Table 120. North America Integrase Inhibitors Sales Market Share by Country (2021-2026) Table 121. North America Integrase Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 122. North America Integrase Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 123. North America Integrase Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Integrase Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Integrase Inhibitors Market Share by Country (2021-2026) Table 126. North America Integrase Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Integrase Inhibitors Market Share Forecast by Country (2027-2032) Table 128. Europe Integrase Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 129. Europe Integrase Inhibitors Sales by Country (2021-2026) & (K Units) Table 130. Europe Integrase Inhibitors Sales Market Share by Country (2021-2026) Table 131. Europe Integrase Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 132. Europe Integrase Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 133. Europe Integrase Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Integrase Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Integrase Inhibitors Market Share by Country (2021-2026) Table 136. Europe Integrase Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Integrase Inhibitors Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Integrase Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Integrase Inhibitors Sales by Country (2021-2026) & (K Units) Table 140. Asia-Pacific Integrase Inhibitors Sales Market Share by Country (2021-2026) Table 141. Asia-Pacific Integrase Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 142. Asia-Pacific Integrase Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Integrase Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Integrase Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Integrase Inhibitors Market Share by Country (2021-2026) Table 146. Asia-Pacific Integrase Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Integrase Inhibitors Market Share Forecast by Country (2027-2032) Table 148. Latin America Integrase Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 149. Latin America Integrase Inhibitors Sales by Country (2021-2026) & (K Units) Table 150. Latin America Integrase Inhibitors Sales Market Share by Country (2021-2026) Table 151. Latin America Integrase Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 152. Latin America Integrase Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 153. Latin America Integrase Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Integrase Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Integrase Inhibitors Market Share by Country (2021-2026) Table 156. Latin America Integrase Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Integrase Inhibitors Market Share Forecast by Country (2027-2032) Table 158. Middle East and Africa Integrase Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 159. Middle East and Africa Integrase Inhibitors Sales by Country (2021-2026) & (K Units) Table 160. Middle East and Africa Integrase Inhibitors Sales Market Share by Country (2021-2026) Table 161. Middle East and Africa Integrase Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 162. Middle East and Africa Integrase Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Integrase Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Integrase Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 165. Middle East and Africa Integrase Inhibitors Market Share by Country (2021-2026) Table 166. Middle East and Africa Integrase Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Middle East and Africa Integrase Inhibitors Market Share Forecast by Country (2027-2032) Table 168. Key Raw Materials Table 169. Raw Materials Key Suppliers Table 170. Integrase Inhibitors Distributors List Table 171. Integrase Inhibitors Customers List Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Integrase Inhibitors Image Figure 2. Global Integrase Inhibitors Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Integrase Inhibitors Market Size (2021-2032) & (US$ Million) Figure 4. Global Integrase Inhibitors Sales (2021-2032) & (K Units) Figure 5. Elvitegravir Image Figure 6. Global Elvitegravir Sales YoY Growth (2021-2032) & (K Units) Figure 7. Bictegravir Image Figure 8. Global Bictegravir Sales YoY Growth (2021-2032) & (K Units) Figure 9. Dolutegravir Image Figure 10. Global Dolutegravir Sales YoY Growth (2021-2032) & (K Units) Figure 11. Raltegravir Image Figure 12. Global Raltegravir Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Integrase Inhibitors Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Integrase Inhibitors Market Share by Type 2025 VS 2032 Figure 15. North America Integrase Inhibitors Sales Market Share in Volume by Type in 2025 Figure 16. North America Integrase Inhibitors Sales Market Share in Value by Type in 2025 Figure 17. Europe Integrase Inhibitors Sales Market Share in Volume by Type in 2025 Figure 18. Europe Integrase Inhibitors Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Integrase Inhibitors Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Integrase Inhibitors Sales Market Share in Value by Type in 2025 Figure 21. Latin America Integrase Inhibitors Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Integrase Inhibitors Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Integrase Inhibitors Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Integrase Inhibitors Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Integrase Inhibitors Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Clinic Image Figure 28. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 29. Hospital Image Figure 30. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Integrase Inhibitors Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Integrase Inhibitors Market Share by Application 2025 VS 2032 Figure 33. North America Integrase Inhibitors Sales Market Share in Volume by Application in 2025 Figure 34. North America Integrase Inhibitors Sales Market Share in Value by Application in 2025 Figure 35. Europe Integrase Inhibitors Sales Market Share in Volume by Application in 2025 Figure 36. Europe Integrase Inhibitors Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Integrase Inhibitors Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Integrase Inhibitors Sales Market Share in Value by Application in 2025 Figure 39. Latin America Integrase Inhibitors Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Integrase Inhibitors Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Integrase Inhibitors Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Integrase Inhibitors Sales Market Share in Value by Application in 2025 Figure 43. North America Integrase Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Integrase Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Integrase Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Integrase Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Integrase Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Integrase Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Integrase Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Integrase Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Integrase Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Integrase Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Integrase Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Integrase Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Integrase Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Integrase Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Integrase Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Integrase Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Integrase Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Integrase Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Integrase Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Integrase Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Integrase Inhibitors Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Integrase Inhibitors Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Elvitegravir
  • Bictegravir
  • Dolutegravir
  • Raltegravir
Applications
  • Clinic
  • Hospital
Companies covered
  • Merck
  • Mylan
  • GlaxoSmithKline
  • Micro Labs
  • Laurus Labs
  • Hetero Drugs
  • Gilead Sciences
  • Cipla
  • Aurobindo Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Integrase Inhibitors Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Integrase Inhibitors Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Integrase Inhibitors Market by Type
  6. 1.3.1 Elvitegravir
  7. 1.3.2 Bictegravir
  8. 1.3.3 Dolutegravir
  9. 1.3.4 Raltegravir
  10. 1.4 Global Integrase Inhibitors Market Size by Type
  11. 1.4.1 Global Integrase Inhibitors Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Integrase Inhibitors Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Integrase Inhibitors Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Integrase Inhibitors Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Integrase Inhibitors Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Integrase Inhibitors Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Integrase Inhibitors Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Integrase Inhibitors Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Integrase Inhibitors Industry Trends
  2. 2.2 Integrase Inhibitors Industry Drivers
  3. 2.3 Integrase Inhibitors Industry Opportunities and Challenges
  4. 2.4 Integrase Inhibitors Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Integrase Inhibitors Revenue (2021-2026)
  2. 3.2 Global Top Players by Integrase Inhibitors Sales (2021-2026)
  3. 3.3 Global Top Players by Integrase Inhibitors Price (2021-2026)
  4. 3.4 Global Integrase Inhibitors Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Integrase Inhibitors Major Company Production Sites & Headquarters
  6. 3.6 Global Integrase Inhibitors Company, Product Type & Application
  7. 3.7 Global Integrase Inhibitors Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Integrase Inhibitors Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Integrase Inhibitors Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Integrase Inhibitors Tier 1, Tier 2, and Tier 3
4 Integrase Inhibitors Regional Status and Outlook
  1. 4.1 Global Integrase Inhibitors Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Integrase Inhibitors Historic Market Size by Region
  3. 4.2.1 Global Integrase Inhibitors Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Integrase Inhibitors Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Integrase Inhibitors Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Integrase Inhibitors Forecasted Market Size by Region
  7. 4.3.1 Global Integrase Inhibitors Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Integrase Inhibitors Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Integrase Inhibitors Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Integrase Inhibitors by Application
  1. 5.1 Integrase Inhibitors Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.2 Global Integrase Inhibitors Market Size by Application
  5. 5.2.1 Global Integrase Inhibitors Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Integrase Inhibitors Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Integrase Inhibitors Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Integrase Inhibitors Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Integrase Inhibitors Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Integrase Inhibitors Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Integrase Inhibitors Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Integrase Inhibitors Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck
  2. 6.1.1 Merck Company Information
  3. 6.1.2 Merck Business Overview
  4. 6.1.3 Merck Integrase Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck Integrase Inhibitors Product Portfolio
  6. 6.1.5 Merck Recent Developments
  7. 6.2 Mylan
  8. 6.2.1 Mylan Company Information
  9. 6.2.2 Mylan Business Overview
  10. 6.2.3 Mylan Integrase Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Mylan Integrase Inhibitors Product Portfolio
  12. 6.2.5 Mylan Recent Developments
  13. 6.3 GlaxoSmithKline
  14. 6.3.1 GlaxoSmithKline Company Information
  15. 6.3.2 GlaxoSmithKline Business Overview
  16. 6.3.3 GlaxoSmithKline Integrase Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GlaxoSmithKline Integrase Inhibitors Product Portfolio
  18. 6.3.5 GlaxoSmithKline Recent Developments
  19. 6.4 Micro Labs
  20. 6.4.1 Micro Labs Company Information
  21. 6.4.2 Micro Labs Business Overview
  22. 6.4.3 Micro Labs Integrase Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Micro Labs Integrase Inhibitors Product Portfolio
  24. 6.4.5 Micro Labs Recent Developments
  25. 6.5 Laurus Labs
  26. 6.5.1 Laurus Labs Company Information
  27. 6.5.2 Laurus Labs Business Overview
  28. 6.5.3 Laurus Labs Integrase Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Laurus Labs Integrase Inhibitors Product Portfolio
  30. 6.5.5 Laurus Labs Recent Developments
  31. 6.6 Hetero Drugs
  32. 6.6.1 Hetero Drugs Company Information
  33. 6.6.2 Hetero Drugs Business Overview
  34. 6.6.3 Hetero Drugs Integrase Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Hetero Drugs Integrase Inhibitors Product Portfolio
  36. 6.6.5 Hetero Drugs Recent Developments
  37. 6.7 Gilead Sciences
  38. 6.7.1 Gilead Sciences Company Information
  39. 6.7.2 Gilead Sciences Business Overview
  40. 6.7.3 Gilead Sciences Integrase Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Gilead Sciences Integrase Inhibitors Product Portfolio
  42. 6.7.5 Gilead Sciences Recent Developments
  43. 6.8 Cipla
  44. 6.8.1 Cipla Company Information
  45. 6.8.2 Cipla Business Overview
  46. 6.8.3 Cipla Integrase Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Cipla Integrase Inhibitors Product Portfolio
  48. 6.8.5 Cipla Recent Developments
  49. 6.9 Aurobindo Pharma
  50. 6.9.1 Aurobindo Pharma Company Information
  51. 6.9.2 Aurobindo Pharma Business Overview
  52. 6.9.3 Aurobindo Pharma Integrase Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Aurobindo Pharma Integrase Inhibitors Product Portfolio
  54. 6.9.5 Aurobindo Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Integrase Inhibitors Sales by Country
  2. 7.1.1 North America Integrase Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Integrase Inhibitors Sales by Country (2021-2026)
  4. 7.1.3 North America Integrase Inhibitors Sales Forecast by Country (2027-2032)
  5. 7.2 North America Integrase Inhibitors Market Size by Country
  6. 7.2.1 North America Integrase Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Integrase Inhibitors Market Size by Country (2021-2026)
  8. 7.2.3 North America Integrase Inhibitors Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Integrase Inhibitors Sales by Country
  2. 8.1.1 Europe Integrase Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Integrase Inhibitors Sales by Country (2021-2026)
  4. 8.1.3 Europe Integrase Inhibitors Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Integrase Inhibitors Market Size by Country
  6. 8.2.1 Europe Integrase Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Integrase Inhibitors Market Size by Country (2021-2026)
  8. 8.2.3 Europe Integrase Inhibitors Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Integrase Inhibitors Sales by Country
  2. 9.1.1 Asia-Pacific Integrase Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Integrase Inhibitors Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Integrase Inhibitors Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Integrase Inhibitors Market Size by Country
  6. 9.2.1 Asia-Pacific Integrase Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Integrase Inhibitors Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Integrase Inhibitors Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Integrase Inhibitors Sales by Country
  2. 10.1.1 South America Integrase Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Integrase Inhibitors Sales by Country (2021-2026)
  4. 10.1.3 South America Integrase Inhibitors Sales Forecast by Country (2027-2032)
  5. 10.2 South America Integrase Inhibitors Market Size by Country
  6. 10.2.1 South America Integrase Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Integrase Inhibitors Market Size by Country (2021-2026)
  8. 10.2.3 South America Integrase Inhibitors Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Integrase Inhibitors Sales by Country
  2. 11.1.1 Middle East and Africa Integrase Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Integrase Inhibitors Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Integrase Inhibitors Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Integrase Inhibitors Market Size by Country
  6. 11.2.1 Middle East and Africa Integrase Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Integrase Inhibitors Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Integrase Inhibitors Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Integrase Inhibitors Value Chain Analysis
  2. 12.1.1 Integrase Inhibitors Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Integrase Inhibitors Production Mode & Process
  7. 12.2 Integrase Inhibitors Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Integrase Inhibitors Distributors
  10. 12.2.3 Integrase Inhibitors Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst